Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Hepatology Communications|April 27, 2026
Liver transplantation is the major determinant of ≥10-year survival in patients with hepatocellular carcinomaMohammad Saeid Rezaee-Zavareh, Joseph C Ahn, Hyunseok Kim, et al.Transplantation Direct|November 2, 2020
Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004-2018 AnalysisNabil Noureddin, Ju Dong Yang, Naim Alkhouri, et al.Gastroenterology|September 28, 2014
Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label studyMichael P Curry, Xavier Forns, Raymond T Chung, et al.Liver Cancer|October 9, 2025
Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular CarcinomaGwang Hyeon Choi, Hyun-Seok Kim, Michael Luu, et al.Hepatology Communications|June 19, 2024
Development and validation of a biomarker index for HCC treatment responseJeff Liang, Po-Yi Li, Joshua Norman, et al.Critical Care (London, England)|January 16, 2020
A lung rescue team improves survival in obesity with acute respiratory distress syndromeGaetano Florio, Matteo Ferrari, Edward A Bittner, et al.NEJM Evidence|January 28, 2025
Larsucosterol for the Treatment of Alcohol-Associated HepatitisMitchell Shiffman, Ben Da, Aparna Goel, et al.Hepatology (Baltimore, Md.)|November 15, 2021
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesSumeet K Asrani, Marwan S Ghabril, Alexander Kuo, et al.Journal of Hepatology|June 14, 2023
The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failureRuben Hernaez, Constantine J Karvellas, Yan Liu, et al.Gastroenterology|May 20, 2015
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver DiseaseMichael Charlton, Gregory T Everson, Steven L Flamm, et al.Pageof 7